Basic MR relaxation mechanisms and contrast agent design
LM De León‐Rodríguez, AF Martins… - Journal of Magnetic …, 2015 - Wiley Online Library
The diagnostic capabilities of magnetic resonance imaging (MRI) have undergone
continuous and substantial evolution by virtue of hardware and software innovations and the …
continuous and substantial evolution by virtue of hardware and software innovations and the …
Nephrogenic systemic fibrosis
R Kaewlai, H Abujudeh - American Journal of …, 2012 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to discuss nephrogenic systemic fibrosis (NSF) in
detail regarding its history, possible pathophysiology, clinical and pathologic presentations …
detail regarding its history, possible pathophysiology, clinical and pathologic presentations …
Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: a systematic review …
SA Woolen, PR Shankar, JJ Gagnier… - JAMA internal …, 2020 - jamanetwork.com
Importance Risk of nephrogenic systemic fibrosis (NSF) to individual patients with stage 4 or
5 chronic kidney disease (CKD; defined as estimated glomerular filtration rate of< 30 …
5 chronic kidney disease (CKD; defined as estimated glomerular filtration rate of< 30 …
Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines
Purpose To retrospectively determine the incidence of nephrogenic systemic fibrosis (NSF)
in a large academic medical center after the adoption of restrictive gadolinium-based …
in a large academic medical center after the adoption of restrictive gadolinium-based …
Development of a suite of gadolinium-free OATP1-targeted paramagnetic probes for liver MRI
SW McRae, M Cleary, D DeRoche… - Journal of Medicinal …, 2023 - ACS Publications
Five amphiphilic, anionic Mn (II) complexes were synthesized as contrast agents targeted to
organic anion transporting polypeptide transporters (OATP) for liver magnetic resonance …
organic anion transporting polypeptide transporters (OATP) for liver magnetic resonance …
Current status of nephrogenic systemic fibrosis
Nephrogenic systemic fibrosis (NSF) occurs in patients with advanced chronic kidney
disease (CKD) or acute renal failure, most commonly following exposure to gadolinium …
disease (CKD) or acute renal failure, most commonly following exposure to gadolinium …
Gadolinium-induced fibrosis
DJ Todd, J Kay - Annual review of medicine, 2016 - annualreviews.org
Gadolinium-based contrast agents (GBCAs), once believed to be safe for patients with renal
disease, have been strongly associated with nephrogenic systemic fibrosis (NSF), a severe …
disease, have been strongly associated with nephrogenic systemic fibrosis (NSF), a severe …
Risks and options with gadolinium-based contrast agents in patients with CKD: a review
MR Rudnick, IM Wahba, AK Leonberg-Yoo… - American Journal of …, 2021 - Elsevier
Gadolinium-based contrast agents (GBCAs) improve the diagnostic capabilities of magnetic
resonance imaging. Although initially believed to be without major adverse effects, GBCA …
resonance imaging. Although initially believed to be without major adverse effects, GBCA …
Acute mesenteric ischemia
JR Stone, LR Wilkins - Techniques in Vascular and Interventional …, 2015 - Elsevier
Acute mesenteric ischemia is a life-threatening condition that occurs when an abrupt
decrease in blood flow results in inadequate supply to the intestines, leading to bowel …
decrease in blood flow results in inadequate supply to the intestines, leading to bowel …
Nephrogenic systemic fibrosis and gadolinium-based contrast agents
AK Abu-Alfa - Advances in chronic kidney disease, 2011 - Elsevier
The strong association between nephrogenic systemic fibrosis (NSF) and exposure to
gadolinium-based contrast agents (GBCAs) has greatly affected the care of patients with …
gadolinium-based contrast agents (GBCAs) has greatly affected the care of patients with …